The cornerstone of today’s medical treatments for cancers has been research and clinical trials.
Since 1979, more than 1,100 Gundersen Health System patients have participated in cancer clinical research studies sponsored by the National Cancer Institute, academic institutions, the pharmaceutical industry and Gundersen Medical Foundation. This means patients in our area have access to the same cutting-edge treatments as the best known names in cancer care and often much earlier than available to the general public.
Essential to the success of research studies is the timely accrual and adequate representation of the patient population. With greater numbers of participants, the sooner the trial will be completed and new improved therapies made available to all cancer patients.
The Cancer and Blood Disorders Center offers research studies for a variety of cancers, including:
- brain/central nervous system cancer
- breast cancer
- gastrointestinal cancer
- genitourinary cancer
- gynecological cancer
- head and neck cancer
- lung cancer
- multiple myeloma
- myelodysplastic syndrome
- pediatric oncology
- prevention/symptom management
Gundersen Health System has about 100 research studies available for cancer patients at any given time.
Our multidisciplinary research nurses and clinical research coordinators support industry-sponsored clinical trials in all non–hematology/oncology specialties. Clinical trials are commonly conducted in the following departments: